4I5P
Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain
Summary for 4I5P
Entry DOI | 10.2210/pdb4i5p/pdb |
Descriptor | Serine/threonine-protein kinase PLK2, (7R)-8-cyclopentyl-7-ethyl-5-methyl-2-(1H-pyrrol-2-yl)-7,8-dihydropteridin-6(5H)-one (3 entities in total) |
Functional Keywords | polo-like kinase-2 (plk-2), synuclein, parkinson's disease, kinase inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole: Q9NYY3 |
Total number of polymer chains | 1 |
Total formula weight | 36157.60 |
Authors | Aubele, D.L.,Hom, R.K.,Adler, M.,Galemmo Jr., R.A.,Bowers, S.,Truong, A.P.,Pan, H.,Beroza, P. (deposition date: 2012-11-28, release date: 2013-12-25, Last modification date: 2024-02-28) |
Primary citation | Aubele, D.L.,Hom, R.K.,Adler, M.,Galemmo, R.A.,Bowers, S.,Truong, A.P.,Pan, H.,Beroza, P.,Neitz, R.J.,Yao, N.,Lin, M.,Tonn, G.,Zhang, H.,Bova, M.P.,Ren, Z.,Tam, D.,Ruslim, L.,Baker, J.,Diep, L.,Fitzgerald, K.,Hoffman, J.,Motter, R.,Fauss, D.,Tanaka, P.,Dappen, M.,Jagodzinski, J.,Chan, W.,Konradi, A.W.,Latimer, L.,Zhu, Y.L.,Sham, H.L.,Anderson, J.P.,Bergeron, M.,Artis, D.R. Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain. Chemmedchem, 8:1295-1313, 2013 Cited by PubMed: 23794260DOI: 10.1002/cmdc.201300166 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.738 Å) |
Structure validation
Download full validation report